PANCREATIC SURGERY WITH THE SINGLE PORT ROBOT: THE FIRST CASE WORLDWIDE AT NIGUARDA HOSPITAL
MINIMALLY INIVASIVE TECHNIQUE ALLOWING SURGERY THROUGH A SINGLE 3 CM INCISION ENABLES MORE PRECISION AND FASTER RECOVERY TIMES
Robotic surgery is expanding into new areas of use with increasingly promising advantages. In Niguarda, the world’s first pancreatic surgery was performed using a state-of-the-art robotic system that allows surgery through a single 3 cm incision (single port).
The surgery was conducted for the resectioning of the pancreatic tail combined with removal of the spleen for an oncological disease in an 85-year-old patient. “The operation was successful and after a few days in the hospital we were able to discharge the patient – explains Giovanni Ferrari, Director of General Oncological and Minimally Invasive Surgery – This is the first example of the world-wide use of the single-port robot for pancreatic surgery, and we hope that the case will also be an impulse for the development of other robot-assisted procedures in the same anatomical district, which remains one of the most delicate to operate on”.
Until now, robotic surgery has been structured by using different access points from which the robot’s surgical arms can pass through, such as the optical viewer and the instruments of the assistants at the surgical table. The new system, on the other hand, has a single arm that brings all the necessary instruments into the surgical area. We have therefore moved from the 4-7 incisions normally required, to a single incision. All this has a major impact on reducing surgical stress even compared to the traditional robotic system. Recovery times are reduced and post-operative pain is mitigated. As a result, patients can be discharged more quickly and return to their daily activities sooner.
The minimally invasive nature of the procedure is also combined with a number of advantages typical of robotic surgery, which are becoming increasingly perfected in the latest generation systems. “The robot, in fact, makes it possible to operate with greater precision, being able to have a vision of the surgery area enlarged by 10 times compared to the vision of the human eye”, Ferrari points out. Added to this, is a three-dimensional vision that allows the surgeon to move easily on several planes. In addition, the movements and rotations of the instruments, mounted on the arm of the robot, ensure better definition of the surgical phases with greater preservation of the anatomical structures of the patient and reduced risks of bleeding.
At Niguarda, the team led by Giovanni Ferrari has performed more than 1,000 robotic procedures (multi-port and single-port) since 2022. “Ninety-five per cent of the cases are cancer patients. We strongly believe in the use of this type of surgery, which has also led us to train abroad, in countries where the use of robots is more widespread. We recently went to Japan to better train ourselves as surgeons in the use of these new technologies”.